Home2023-05-23T14:19:15+00:00

Unleash the Power of Therapeutics

MESOX has IP-protected carriers to improve the bioavailability and efficacy of pharmaceuticals. We partner with pharmaceutical and biotechnology companies to bring challenging therapeutics to market.

Pioneering porous carrier technology

Our solutions aim to reduce the unnecessary dose exposure or frequency and improve patient compliance, ultimately leading to better patient outcomes.

Our carrier technology is widely applicable for the delivery of different molecules and therapeutic modalities. The carrier is cellulosic in nature and has pores within the meso size range (2-50 nm) which gives it unique applications for:

  • Small molecules - enhancing bioavailability, amorphous form stability and controlled-release applications

  • Mid-sized molecules – optimising the delivery of beyond rule of 5 molecules e.g. PROTACs and molecular glues

  • Peptides Pushing the boundaries of what's deliverable to mucosal/other tissues

Our technology lends itself to many applications due to the nature of carrier essentially acting as a micro-container ready for loading of therapeutics molecules.

Pioneering porous carrier technology

Our solutions aim to reduce the unnecessary dose exposure or frequency and improve patient compliance, ultimately leading to better patient outcomes.

Our carrier technology is widely applicable for the delivery of different molecules and therapeutic modalities. The carrier is cellulosic in nature and has pores within the meso size range (2-50 nm) which gives it unique applications for:

  • Small molecules - enhancing bioavailability, amorphous form stability and controlled-release applications

  • Mid-sized molecules – optimising the delivery of beyond rule of 5 molecules e.g. PROTACs and molecular glues

  • Peptides Pushing the boundaries of what's deliverable to mucosal/other tissues

Our technology lends itself to many applications due to the nature of carrier essentially acting as a micro-container ready for loading of therapeutics molecules.

Patented platform for Superior Bioavailability

Achieving superior absorption and stability for therapeutic molecules

Carrier from FDA-approved material

Carrier thoroughly tested both in vitro and in vivo

Scalable manufacturing process

to pilot/commercial scales via a streamlined agreement

Widely applicable technology

Cutting-edge technology that is suitable for different molecules

Recent News

Go to Top